Publications by authors named "Peter Turcsanyi"

Claim this Profile
I
Idelalisib plus rituximab versus ibrutinib in the treatment of relapsed/refractory chronic lymphocytic leukaemia: A real-world analysis from the Chronic Lymphocytic Leukemia Patients Registry (CLLEAR).
Martin Špaček, Lukáš Smolej, Martin Šimkovič, Lucie Nekvindová, Zlatuše Křístková

Br J Haematol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 in patients with chronic lymphocytic leukemia: a multicenter analysis by the Czech CLL study group.
Martin Šimkovič, Peter Turcsányi, Martin Špaček, Jana Mihályová, Pavlína Ryznerová

Ann Hematol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rare germline ATM variants of uncertain significance in chronic lymphocytic leukaemia and other cancers.
Anna Petrackova, Jakub Savara, Peter Turcsanyi, Petr Gajdos, Tomas Papajik

Br J Haematol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revisiting Richter transformation in the era of novel CLL agents.
Anna Petrackova, Peter Turcsanyi, Tomas Papajik, Eva Kriegova

Blood Rev· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards a Better Characterisation of Leukemic Cells in Chronic Lymphocytic Leukaemia: Cell-Size Heterogeneity Reflects Their Activation Status and Migratory Abilities.
Gayane Manukyan, Zuzana Mikulkova, Peter Turcsanyi, Jakub Savara, Markéta Trajerová

Cancers (Basel)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High CXCR3 on Leukemic Cells Distinguishes from in Chronic Lymphocytic Leukemia: Evidence from CD5 and CD5 Clones.
Gayane Manukyan, Tomas Papajik, Zuzana Mikulkova, Renata Urbanova, Veronika Smotkova Kraiczova, Peter Turcsanyi

J Immunol Res· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External validation of International Prognostic Score for asymptomatic early stage chronic lymphocytic leukaemia and proposal of an alternative score.
Lukáš Smolej, Peter Turcsányi, Zuzana Kubová, Jana Zuchnická, Jana Mihályová

Br J Haematol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deciphering the complex circulating immune cell microenvironment in chronic lymphocytic leukaemia using patient similarity networks.
Zuzana Mikulkova, Gayane Manukyan, Peter Turcsanyi, Milos Kudelka, Renata Urbanova

Sci Rep· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistance-Associated Mutations in Chronic Lymphocytic Leukemia Patients Treated With Novel Agents.
Lenka Sedlarikova, Anna Petrackova, Tomas Papajik, Peter Turcsanyi, Eva Kriegova

Front Oncol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complex karyotype as a predictor of high-risk chronic lymphocytic leukemia: A single center experience over 12 years.
Lenka Kruzova, Petra Schneiderova, Milena Holzerova, Michaela Vatolikova, Martina Divoka, Peter Turcsanyi

Leuk Res· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving risk-stratification of patients with chronic lymphocytic leukemia using multivariate patient similarity networks.
Peter Turcsanyi, Eva Kriegova, Milos Kudelka, Martin Radvansky, Lenka Kruzova

Leuk Res· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic changes in HLA-DR expression during short-term and long-term ibrutinib treatment in patients with chronic lymphocytic leukemia.
Gayane Manukyan, Peter Turcsanyi, Zuzana Mikulkova, Gabriela Gabcova, Renata Urbanova

Leuk Res· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutrophils in chronic lymphocytic leukemia are permanently activated and have functional defects.
Gayane Manukyan, Tomas Papajik, Petr Gajdos, Zuzana Mikulkova, Renata Urbanova

Oncotarget· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Numbers of CD8+PD-1+ and CD4+PD-1+ Cells in Peripheral Blood of Patients with Chronic Lymphocytic Leukemia Are Independent of Binet Stage and Are Significantly Higher Compared to Healthy Volunteers.
Martin Novák, Vit Procházka, Peter Turcsányi, Tomáš Papajík

Acta Haematol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spontaneous splenic rupture in a patient with acute promyelocytic leukaemia during induction chemotherapy.
Adam Kuba, Tomas Szotkowski, Peter Rohon, Edgar Faber, Peter Turcsanyi

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography examination in patients with chronic lymphocytic leukemia may reveal Richter transformation.
Tomáš Papajík, Miroslav Mysliveček, Renata Urbanová, Eva Buriánková, Zuzana Kapitáňová

Leuk Lymphoma· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis